Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Investing.com - Evolent Health Inc (NYSE: EVH) reported fourth quarter EPS of $-0.02, $0.09 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $646.5M versus the consensus estimate of $652.2M.
Guidance
Evolent Health Inc sees Q1 2025 revenue of $2.06B-$2.11B versus the analyst consensus of $2.42B.
Evolent Health Inc’s stock price closed at $10.73. It is down -4.62% in the last 3 months and down -64.13% in the last 12 months.
Evolent Health Inc saw 1 positive EPS revisions and 8 negative EPS revisions in the last 90 days. See Evolent Health Inc’s stock price’s past reactions to earnings here.
According to InvestingPro, Evolent Health Inc’s Financial Health score is "great performance".
Check out Evolent Health Inc’s recent earnings performance, and Evolent Health Inc’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar